Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes
Abstract The clinical and metabolic interactions between hepatitis C virus (HCV) infection and diabetes mellitus (DM) are well documented. The study aimed to compare HCV-infected patients with and without DM. The analysis included 18,968 patients treated with direct-acting antivirals (DAAs) between...
Saved in:
| Main Authors: | Michał Brzdęk, Dorota Zarębska-Michaluk, Piotr Rzymski, Beata Lorenc, Justyna Janocha-Litwin, Hanna Berak, Krzysztof Tomasiewicz, Marek Sitko, Włodzimierz Mazur, Ewa Janczewska, Dorota Dybowska, Jakub Klapaczyński, Anna Parfieniuk-Kowerda, Jerzy Jaroszewicz, Anna Piekarska, Robert Flisiak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-06290-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination
by: Dorota Zarębska-Michaluk, et al.
Published: (2024-10-01) -
Correction: Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination
by: Dorota Zarębska-Michaluk, et al.
Published: (2024-11-01) -
Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
by: Aleksandra Berkan-Kawińska, et al.
Published: (2024-07-01) -
Hospitalizations and deaths among people coinfected with HIV and HCV
by: Dorota Zarębska-Michaluk, et al.
Published: (2024-11-01) -
Difference in Optical Coherence Tomography Angiography Parameters After SARS-CoV-2 Infection During the Alpha and Delta Variant Dominance Periods
by: Magdalena Kal, et al.
Published: (2024-12-01)